Table 3. Complete Clinical Response (CCR) at the Index Lesion According to Baseline Characteristics.

Subgroup	No. of Participants	% CCR		Difference in %
		WR279,396	Placebo	Observed (95% CI)	Adjusted (95% CI)
Center					22 (7, 37)
Paris, France	10	80	40	40 (−15, 95)
Sidi Bouzid, Tunisia	82	96	76	20 (5, 35)
Male sex					22 (7, 37)
Yes	54	93	67	26 (6, 46)
No	38	96	80	16 (−6, 38)
Age <18 years					16 (1, 30)
Yes	80	96	82	14 (0, 28)
No	12	67	33	33 (−28, 95)
Single baseline lesion					24 (10, 38)
Yes	54	96	88	8 (−6, 22)
No	38	91	44	47 (20, 74)
Index lesion <100 mm2					22 (6, 37)
Yes	46	96	78	19 (−2, 39)
No	46	91	67	24 (2, 47)
Index lesion on upper body					23 (7, 38)
Yes	37	100	71	29 (8, 51)
No	55	90	72	18 (−3, 39)
Lesion noticed <60 days before treatment					23 (7, 38)
Yes	43	96	70	26 (4, 47)
No	49	93	73	20 (−1, 41)